Masimo Corporation (NASDAQ:MASI) Receives Average Recommendation of "Hold" from Brokerages

Key Points

• Masimo has received an average analyst recommendation of "Hold" from nine covering analysts (1 sell, 7 hold, 1 buy), with an average 1‑year price target of $181.17.
• Several firms recently downgraded the stock—BTIG, Wolfe Research, and Piper Sandler moved ratings toward neutral/hold while Weiss Ratings reiterated a sell—indicating waning analyst enthusiasm.
• The shares trade around $176.89 with a market cap of about $9.5B, a negative PE (-16.78) and a one‑year range of $125.94–$179.00, and institutional investors own roughly 85.96% of the company with recent sizable buys by Jupiter Asset Management and Citigroup.

Masimo Corporation (NASDAQ:MASI - Get Free Report) has been given an average recommendation of "Hold" by the nine analysts that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $181.1667.

MASI has been the topic of a number of recent research reports. BTIG Research cut shares of Masimo from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 18th. Stifel Nicolaus set a $180.00 price target on shares of Masimo in a report on Tuesday, February 17th. Wolfe Research downgraded shares of Masimo from a "strong-buy" rating to a "hold" rating in a research note on Thursday, February 19th. Weiss Ratings reiterated a "sell (d)" rating on shares of Masimo in a report on Thursday, January 22nd. Finally, Piper Sandler cut shares of Masimo from an "overweight" rating to a "hold" rating and set a $180.00 price objective for the company. in a research report on Tuesday, February 17th.

Masimo Stock Performance

Masimo stock opened at $176.89 on Friday. The firm has a market capitalization of $9.50 billion, a PE ratio of -16.78, a price-to-earnings-growth ratio of 1.80 and a beta of 1.21. Masimo has a one year low of $125.94 and a one year high of $179.00. The stock's 50 day moving average price is $159.23 and its 200 day moving average price is $148.12. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Jupiter Asset Management Ltd. purchased a new position in shares of Masimo during the 3rd quarter valued at approximately $12,491,000. American Century Companies Inc. increased its stake in shares of Masimo by 10.6% in the third quarter. American Century Companies Inc. now owns 168,341 shares of the medical equipment provider's stock worth $24,839,000 after buying an additional 16,113 shares during the last quarter. 4D Advisors LLC raised its holdings in Masimo by 50.0% in the second quarter. 4D Advisors LLC now owns 45,000 shares of the medical equipment provider's stock valued at $7,570,000 after acquiring an additional 15,000 shares in the last quarter. ING Groep NV acquired a new stake in Masimo in the third quarter valued at $3,069,000. Finally, Citigroup Inc. boosted its stake in Masimo by 133.5% during the 3rd quarter. Citigroup Inc. now owns 116,672 shares of the medical equipment provider's stock valued at $17,215,000 after acquiring an additional 66,710 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company's stock.

About Masimo

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.